Lv1
40 积分 2025-07-26 加入
Therapeutic Effects of PCSK9 Inhibitors on Lp(a)-Associated Atherosclerosis: Evidence and Perspectives
4分钟前
待确认
MiR-146a encapsulated liposomes reduce vascular inflammatory responses through decrease of ICAM-1 expression, macrophage activation, and foam cell formation
3小时前
已完结
Relationship Between the Severity of Coronary Artery Disease and Renal Function
3个月前
已完结
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction
3个月前
已完结
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques
4个月前
已完结
Early Initiation of PCSK9 Inhibitor Therapy Versus Placebo in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
9个月前
已完结
Lipoprotein(a) lowering and cardiovascular risk reduction by PCSK9 inhibitors
9个月前
已完结
Salvianic acid A ameliorates atherosclerosis through metabolic-dependent anti-EndMT pathway and repression of TGF-β/ALK5 signaling
1年前
已完结
皖公网安备34019202002308
